DSCC1 and neoplasm: Cox regression analysis of the METABRIC and KASH cohorts showed that high DSCC1 expression was a significant predictor of shorter survival regardless of tumor size, lymph node status, and tumor grade (hazard ratio (HR) = 1.325; 95% confidence interval (CI) 1.098–1.599; p = 0.003 in METABRIC and HR = 6.381; 95% CI 1.489–27.339; p = 0.013 in KASH; Table 3).